Selected research
Industry Growth & Trends
Global In-vitro Toxicity Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global In-vitro Toxicity Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for In-vitro Toxicity Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the In-vitro Toxicity Testing market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., General Electric Co., Evotec AG, Eurofins GSC Lux Sarl, Charles River Laboratories International Inc., CELTHER POLSKA Sp z o.o. and Bio-Rad Laboratories Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global In-vitro Toxicity Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The In-vitro Toxicity Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global In-vitro Toxicity Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to In-vitro Toxicity Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global In-vitro Toxicity Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
In-vitro Toxicity Testing Market by Company
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies Inc.
General Electric Co.
Evotec AG
Eurofins GSC Lux Sarl
Charles River Laboratories International Inc.
CELTHER POLSKA Sp z o.o.
Bio-Rad Laboratories Inc.
Abbott Laboratories
In-vitro Toxicity Testing Segment by Type
Static Well Plate System
Multi-compartmental Perfused Systems
In-vitro Toxicity Testing Segment by Application
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
In-vitro Toxicity Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-vitro Toxicity Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-vitro Toxicity Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-vitro Toxicity Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of In-vitro Toxicity Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Static Well Plate System
- Multi-compartmental Perfused Systems
Applications
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutions
- Others
Companies covered
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies Inc.
- General Electric Co.
- Evotec AG
- Eurofins GSC Lux Sarl
- Charles River Laboratories International Inc.
- CELTHER POLSKA Sp z o.o.
- Bio-Rad Laboratories Inc.
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global In-vitro Toxicity Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global In-vitro Toxicity Testing Market Size by Region (2021-2032)
- 1.4.1 Global In-vitro Toxicity Testing Market Size by Region (2021-2026)
- 1.4.2 Global In-vitro Toxicity Testing Market Size by Region (2027-2032)
- 1.5 Key Regions In-vitro Toxicity Testing Market Size (2021-2032)
- 1.5.1 North America In-vitro Toxicity Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe In-vitro Toxicity Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific In-vitro Toxicity Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America In-vitro Toxicity Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa In-vitro Toxicity Testing Market Size Growth Rate (2021-2032)
2 In-vitro Toxicity Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 Static Well Plate System
- 2.1.2 Multi-compartmental Perfused Systems
- 2.2 Global In-vitro Toxicity Testing Market Size by Type
- 2.2.1 Global In-vitro Toxicity Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global In-vitro Toxicity Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global In-vitro Toxicity Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global In-vitro Toxicity Testing Market Size by Regions
- 2.3.1 North America In-vitro Toxicity Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe In-vitro Toxicity Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America In-vitro Toxicity Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa In-vitro Toxicity Testing Market Size Breakdown by Type (2021-2026)
3 In-vitro Toxicity Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical and Biotechnology Companies
- 3.1.2 Academic and Research Institutions
- 3.1.3 Others
- 3.2 Global In-vitro Toxicity Testing Market Size by Application
- 3.2.1 Global In-vitro Toxicity Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global In-vitro Toxicity Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global In-vitro Toxicity Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global In-vitro Toxicity Testing Market Size by Regions
- 3.3.1 North America In-vitro Toxicity Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe In-vitro Toxicity Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America In-vitro Toxicity Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa In-vitro Toxicity Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 In-vitro Toxicity Testing Industry Trends
- 4.2 In-vitro Toxicity Testing Industry Drivers
- 4.3 In-vitro Toxicity Testing Industry Opportunities and Challenges
- 4.4 In-vitro Toxicity Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by In-vitro Toxicity Testing Revenue (2021-2026)
- 5.2 Global In-vitro Toxicity Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global In-vitro Toxicity Testing Key Company Headquarters & Area Served
- 5.4 Global In-vitro Toxicity Testing Company, Product Type & Application
- 5.5 Global In-vitro Toxicity Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global In-vitro Toxicity Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 In-vitro Toxicity Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 In-vitro Toxicity Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific Inc.
- 6.1.1 Thermo Fisher Scientific Inc. Company Information
- 6.1.2 Thermo Fisher Scientific Inc. Business Overview
- 6.1.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Portfolio
- 6.1.5 Thermo Fisher Scientific Inc. Recent Developments
- 6.2 Merck KGaA
- 6.2.1 Merck KGaA Company Information
- 6.2.2 Merck KGaA Business Overview
- 6.2.3 Merck KGaA In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck KGaA In-vitro Toxicity Testing Product Portfolio
- 6.2.5 Merck KGaA Recent Developments
- 6.3 Agilent Technologies Inc.
- 6.3.1 Agilent Technologies Inc. Company Information
- 6.3.2 Agilent Technologies Inc. Business Overview
- 6.3.3 Agilent Technologies Inc. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Agilent Technologies Inc. In-vitro Toxicity Testing Product Portfolio
- 6.3.5 Agilent Technologies Inc. Recent Developments
- 6.4 General Electric Co.
- 6.4.1 General Electric Co. Company Information
- 6.4.2 General Electric Co. Business Overview
- 6.4.3 General Electric Co. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 General Electric Co. In-vitro Toxicity Testing Product Portfolio
- 6.4.5 General Electric Co. Recent Developments
- 6.5 Evotec AG
- 6.5.1 Evotec AG Company Information
- 6.5.2 Evotec AG Business Overview
- 6.5.3 Evotec AG In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Evotec AG In-vitro Toxicity Testing Product Portfolio
- 6.5.5 Evotec AG Recent Developments
- 6.6 Eurofins GSC Lux Sarl
- 6.6.1 Eurofins GSC Lux Sarl Company Information
- 6.6.2 Eurofins GSC Lux Sarl Business Overview
- 6.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Portfolio
- 6.6.5 Eurofins GSC Lux Sarl Recent Developments
- 6.7 Charles River Laboratories International Inc.
- 6.7.1 Charles River Laboratories International Inc. Company Information
- 6.7.2 Charles River Laboratories International Inc. Business Overview
- 6.7.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Portfolio
- 6.7.5 Charles River Laboratories International Inc. Recent Developments
- 6.8 CELTHER POLSKA Sp z o.o.
- 6.8.1 CELTHER POLSKA Sp z o.o. Company Information
- 6.8.2 CELTHER POLSKA Sp z o.o. Business Overview
- 6.8.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Portfolio
- 6.8.5 CELTHER POLSKA Sp z o.o. Recent Developments
- 6.9 Bio-Rad Laboratories Inc.
- 6.9.1 Bio-Rad Laboratories Inc. Company Information
- 6.9.2 Bio-Rad Laboratories Inc. Business Overview
- 6.9.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Portfolio
- 6.9.5 Bio-Rad Laboratories Inc. Recent Developments
- 6.10 Abbott Laboratories
- 6.10.1 Abbott Laboratories Company Information
- 6.10.2 Abbott Laboratories Business Overview
- 6.10.3 Abbott Laboratories In-vitro Toxicity Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Abbott Laboratories In-vitro Toxicity Testing Product Portfolio
- 6.10.5 Abbott Laboratories Recent Developments
7 North America
- 7.1 North America In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 7.3 North America In-vitro Toxicity Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 8.3 Europe In-vitro Toxicity Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific In-vitro Toxicity Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 10.3 South America In-vitro Toxicity Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa In-vitro Toxicity Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa In-vitro Toxicity Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst